Description Why Tesamorelin is the Reference GHRH Analog in Metabolic Research FDA-approved GHRH analogue (Egrifta) -15.2% visceral fat, +81% IGF-1 in Phase III trial (n=412) FDA Approved Egrifta (2010) The only FDA-approved GHRH analogue for reducing excess abdominal fat in HIV-positive adults with lipodystrophy
We work with a wide range of carriers to make this easier, including: Florida Blue Aetna Cigna United Healthcare Medicare and Medicaid If you carry one of these plans and your injections are medically necessary, your cost may come down to a standard copay, or the visit may be covered once your deductible is met
Call at 0203 824 2840 to speak to a team member
ADVANCED NANO GLUTATHIONE ABSORPTION Our formula uses cutting-edge nano delivery technology for superior bioavailability, ensuring more glutathione reaches your cells compared to standard or liposomal forms
Produced in the liver, glutathione assists with detoxifying xenobiotics and heavy metals, neutralizes hydrogen peroxide, maintains the integrity of blood cells, and helps to transport amino acids across cell membranes